Table 3.

Comparison of GP trainees and GPs’ attitudes toward naloxone

VariableGP trainee, n (%) n= 136GP, n (%) n= 448P-valuea
In favour of a lay naloxone project84/132 (63.6)292/442 (66.1)0.741
Would take part in project71/123 (57.7)140/443 (31.6)<0.001b
First preference single-use injectable naloxone26/123 (21.1)47/367 (12.8)0.035
First preference multidose injectable naloxone23/117 (19.7)11/338 (3.3)<0.001b
First preference intranasal naloxone73/124 (58.9)331/405 (81.7)<0.001b
  • All tests are 2 x 2 χ2 tests for association, as the variables are categorical and independent. Missing values were excluded.

  • a As multiple testing (15 comparisons) was performed, a Bonferroni adjustment to the 0.05 α level was applied to limit the potential of a type 1 error.

  • b A P-value0.003 is considered significant in this context.